SCHEMBL484580

SCHEMBL484580

O=C(NC1CCc2ccc(C(=O)N3CCC4(CCN(Cc5ccccn5)CC4)CC3)cc21)c1cc(Cl)ccc1F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 3/20 0.43
ADRA1A P35348 3/20 0.43
F10 P00742 1/20 0.41
CYP2D6 P10635 3/20 0.40
CYP3A4 P08684 3/20 0.40
CYP2C19 P33261 3/20 0.40
CYP1A2 P05177 2/20 0.40
CYP2C9 P11712 2/20 0.40
MAPK1 P28482 2/20 0.40
CHRM2 P08172 2/20 0.40
CHRM3 P20309 1/20 0.40
DRD4 P21917 1/20 0.40
TSHR P16473 3/20 0.40
ALDH1A1 P00352 2/20 0.40
KDM4E B2RXH2 1/20 0.40
MAPT P10636 1/20 0.40
THRB P10828 1/20 0.39
ACKR3 P25106 1/20 0.39
CCR8 P51685 1/20 0.38
KCNH2 Q12809 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL484721 0.90 ALDH1A1 (0.42) HTR1AADRA1AF10CYP2D6CYP3A4
SCHEMBL485609 0.89 CYP3A4 (0.37) HTR1AADRA1ACYP2D6CYP3A4CYP2C19
SCHEMBL485046 0.88 CYP3A4 (0.52) CYP2D6CYP3A4CYP2C19CYP1A2CYP2C9
SCHEMBL484647 0.88 CYP2D6 (0.43) HTR1AADRA1ACYP2D6CYP3A4CYP2C19
SCHEMBL484626 0.86 CYP2D6 (0.39) HTR1ACYP2D6CYP3A4CYP2C19CYP1A2
SCHEMBL2822137 0.86 CYP3A4 (0.41) HTR1ACYP2D6CYP3A4CYP2C19CYP1A2
SCHEMBL485047 0.86 MCHR1 (0.46) CYP2D6CYP3A4CYP2C19CYP1A2CYP2C9
SCHEMBL485274 0.86 USP2 (0.43) CYP2D6CYP3A4CYP2C9TSHRALDH1A1
SCHEMBL484783 0.86 CHRM2 (0.45) HTR1ACYP2D6CYP3A4CYP2C19CYP1A2
SCHEMBL485106 0.85 CYP2D6 (0.49) CYP2D6CYP3A4CYP1A2CYP2C9MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US claimed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US claimed
EP-2411381-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-02-01 EP claimed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US claimed
WO-2010108651-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2010-09-30 WO claimed
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US disclosed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US disclosed
EP-2411381-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-02-01 EP disclosed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US disclosed
WO-2010108651-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2010-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130231327-A1 Substituted Spiro-Amide Compounds BDKRB1, BDKRB2, REN HTR1A 610/4885ADRA1A 97/4885F10 857/4885
US-20100249095-A1 Substituted Spiro-amide Compounds BDKRB1, BDKRB2, REN HTR1A 610/4885ADRA1A 97/4885F10 857/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.